The FDA is committed to addressing the countrywide disaster of opioid habit on all fronts, with a substantial focus on reducing exposure to opioids and stopping new dependancy; supporting the remedy of People with opioid use disorder; fostering the development of novel pain treatment therapies and opioids much more resistant to abuse and misuse; an